UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 51

Sortiert nach

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus

Endocrinology and metabolism clinics of North America, 2014-09, Vol.43 (3), p.685-696

2014

Link zum Volltext

Verfügbarkeit prüfen

Sofosbuvir for treatment of chronic hepatitis C

Hepatology international, 2015-04, Vol.9 (2), p.161-173

2015

Link zum Volltext

Verfügbarkeit prüfen

Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment

Addiction science & clinical practice, 2024-03, Vol.19 (1), p.22-22

2024

Link zum Volltext

Verfügbarkeit prüfen

PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV

Open forum infectious diseases, 2022-10, Vol.9 (10), p.ofac476-ofac476

2022

Link zum Volltext

Verfügbarkeit prüfen

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment

World journal of hepatology, 2016-11, Vol.8 (31), p.1318-1326

2016

Link zum Volltext

Verfügbarkeit prüfen

Expanding the Evidence on Integrated Opioid Use Disorder and Infectious Disease Care

Journal of addiction medicine, 2021-11, Vol.15 (6), p.452

2021

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C virus (HCV)-specific T cell confer resistance to HCV re-infection after sustained virologic response in a non-cytolytic fashion among people who inject drugs: results from ANCHOR study

Journal of hepatology, 2022-07, Vol.77, p.S571

2022

Link zum Volltext

Verfügbarkeit prüfen

Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial

Annals of internal medicine, 2017-09, Vol.167 (5), p.311

2017

Link zum Volltext

Verfügbarkeit prüfen

Opioids and Infectious Diseases: A Converging Public Health Crisis

The Journal of infectious diseases, 2019-07, Vol.220 (3), p.346-349

2019

Link zum Volltext

Verfügbarkeit prüfen

Long-term outcomes associated with task-shifting of HCV treatment by non-specialist providers: five year follow-up from the ASCEND cohort

Journal of hepatology, 2022-07, Vol.77, p.S574

2022

Link zum Volltext

Verfügbarkeit prüfen

Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs

Clinical infectious diseases, 2020-10, Vol.71 (7), p.1715-1722

2020

Link zum Volltext

Verfügbarkeit prüfen

Diabetes Mellitus Type II and Abnormal Glucose Metabolism in the setting of HIV

Endocrinology and metabolism clinics of North America, 2014-09, Vol.43 (3), p.685-696

2014

Link zum Volltext

Verfügbarkeit prüfen

Association of sustained virologic response with measures of direct-acting antiviral adherence in patients with Hepatitis C: data from the ASCEND and ANCHOR investigations

Journal of hepatology, 2022-07, Vol.77, p.S552

2022

Link zum Volltext

Verfügbarkeit prüfen

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus: HIV and Endocrine Disorders

Endocrinology and metabolism clinics of North America, 2014, Vol.43 (3)

2014

Link zum Volltext

Verfügbarkeit prüfen

Expansion of Treatment for Hepatitis C Virus Infection

Annals of internal medicine, 2018-03, Vol.168 (6), p.457

2018

Link zum Volltext

Verfügbarkeit prüfen

No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV

The Journal of infectious diseases, 2017-12, Vol.217 (1), p.47-50

2017

Link zum Volltext

Verfügbarkeit prüfen

HCV reinfection associated with IDU and cocaine use in a cohort of people with OUD: 4 Year follow-up data from the ANCHOR cohort

Journal of hepatology, 2022-07, Vol.77, p.S572

2022

Link zum Volltext

Verfügbarkeit prüfen

“I got so much on my plate”: Understanding care discontinuity for HIV and HCV among formerly incarcerated persons

Health services research, 2023-08, Vol.58 (4), p.865-872

2023

Link zum Volltext

Verfügbarkeit prüfen

A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

Journal of hepatology, 2019-09, Vol.71 (3), p.498-504

2019

Link zum Volltext

Verfügbarkeit prüfen

Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections

AIDS (London), 2023-10, Vol.37 (12), p.1799

2023

Link zum Volltext

Verfügbarkeit prüfen

Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns

Journal of neurovirology, 2018-12, Vol.24 (6), p.670-678

2018

Link zum Volltext

Verfügbarkeit prüfen

100. "They Never Asked Me": A Mixed-Methods Study to Evaluate the INJECT-RESPECT Tool for Assessing Infectious and Non-Infectious risks of Injection Drug Use

Open forum infectious diseases, 2023-11, Vol.10 (Supplement_2)

2023

Link zum Volltext

Verfügbarkeit prüfen

Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C

Clinical microbiology reviews, 2017-01, Vol.30 (1), p.23-42

2017

Link zum Volltext

Verfügbarkeit prüfen

Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance

Clinical infectious diseases, 2019-08, Vol.69 (4), p.571-576

2019

Link zum Volltext

Verfügbarkeit prüfen

Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use

The International journal of drug policy, 2023-01, Vol.111, p.103906-103906, Article 103906

2023

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 51

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(47)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(51)

Sprache

Englisch
(51)
Japanisch
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(32)
Science & Technology
(32)
Humans
(24)
Hepatitis C
(15)
Infectious Diseases
(13)
Antiviral Agents - Therapeutic Use
(11)
Female
(10)
Hepatitis C, Chronic - Drug Therapy
(10)
Hiv
(10)
Immunology
(10)
Male
(10)
Microbiology
(9)
Human Immunodeficiency Virus
(8)
Hcv
(7)
Middle Aged
(7)
Adult
(6)
Hepatitis C Virus
(6)
Abstracts
(5)
Antiviral Drugs
(5)
Drug Therapy
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus

Sofosbuvir for treatment of chronic hepatitis C

Hospitalization is a missed opportunity for HIV screening, pre-exposure prophylaxis, and treatment

PrEP Indications and PrEP Knowledge, Access, and Interest Among Individuals With HCV

Safe and effective sofosbuvir-based therapy in patients with mental health disease on hepatitis C virus treatment

Expanding the Evidence on Integrated Opioid Use Disorder and Infectious Disease Care

Hepatitis C virus (HCV)-specific T cell confer resistance to HCV re-infection after sustained virologic response in a non-cytolytic fashion among people who inject drugs: results from ANCHOR study

Expansion of Treatment for Hepatitis C Virus Infection by Task Shifting to Community-Based Nonspecialist Providers: A Nonrandomized Clinical Trial

Opioids and Infectious Diseases: A Converging Public Health Crisis

Long-term outcomes associated with task-shifting of HCV treatment by non-specialist providers: five year follow-up from the ASCEND cohort

Concurrent Initiation of Hepatitis C and Opioid Use Disorder Treatment in People Who Inject Drugs

Diabetes Mellitus Type II and Abnormal Glucose Metabolism in the setting of HIV

Association of sustained virologic response with measures of direct-acting antiviral adherence in patients with Hepatitis C: data from the ASCEND and ANCHOR investigations

Diabetes Mellitus Type 2 and Abnormal Glucose Metabolism in the Setting of Human Immunodeficiency Virus: HIV and Endocrine Disorders

Expansion of Treatment for Hepatitis C Virus Infection

No Improvement in Hemoglobin A1c Following Hepatitis C Viral Clearance in Patients With and Without HIV

HCV reinfection associated with IDU and cocaine use in a cohort of people with OUD: 4 Year follow-up data from the ANCHOR cohort

“I got so much on my plate”: Understanding care discontinuity for HIV and HCV among formerly incarcerated persons

A pilot study of safety and efficacy of HCV retreatment with sofosbuvir/velpatasvir/voxilaprevir in patients with or without HIV (RESOLVE STUDY)

Undertreatment of opioid use disorder in patients hospitalized with injection drug use-associated infections

Mechanisms of neuropathogenesis in HIV and HCV: similarities, differences, and unknowns

100. "They Never Asked Me": A Mixed-Methods Study to Evaluate the INJECT-RESPECT Tool for Assessing Infectious and Non-Infectious risks of Injection Drug Use

Clinical Laboratory Testing in the Era of Directly Acting Antiviral Therapies for Hepatitis C

Testosterone in Men With Chronic Hepatitis C Infection and After Hepatitis C Viral Clearance

Hepatitis C cure and medications for opioid use disorder improve health-related quality of life in patients with opioid use disorder actively engaged in substance use

Suchergebnisse filtern